
    
      Methods: The study will be authorized by the Ziv Helsinki Committee. Informed consent and
      questionnaire will obtained from all subjects before study entry. We will examine 120
      volunteers in a blind fashion, including 60 MS patients diagnosed by a neurologist based on
      clinical, laboratory and MRI findings. Patients will be evaluated according to EDSS score.
      The control group will include 50 age and gender matched healthy volunteers and 10 more
      patients with unrelated neurological diseases. Inclusion criteria: Age 18-60; Exclusion
      criteria: Other diseases, pathologies, or immune system disorders. Here, we will examine
      expression of different fatty acids in the serum and in erythrocyte samples; Monitor
      mitochondrial transmembrane potential as marker for the mitochondria general function.
    
  